Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „available“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · The safety profile of ADCETRIS is based on available clinical trial data, the Named Patient Program (NPP), and
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · No post-marketing surveillance data are available following Adjupanrix administration.
Eintrag öffnenAdvagraf · 4.5 · Metabolic interactions Systemically available tacrolimus is metabolised by hepatic CYP3A4. There is also evide
Eintrag öffnenAptivus · 4.5 · 19 H2-receptor antagonists No interaction study No data are available for An increase in gastric pH that perfo
Eintrag öffnenAptivus · 4.8 · Limited data are currently available for the use of Aptivus, co-administered with low dose ritonavir, in patie
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenArava · 4.3 · • Patients with moderate to severe renal insufficiency, because insufficient clinical experience is available
Eintrag öffnenArava · 4.5 · No clinical data are available on the efficacy and safety of vaccinations under leflunomide treatment. Vaccina
Eintrag öffnenArava · 4.5 · No clinical data are available on the efficacy and safety of vaccinations under leflunomide treatment. Vaccina
Eintrag öffnenArava · 4.5 · No clinical data are available on the efficacy and safety of vaccinations under leflunomide treatment. Vaccina
Eintrag öffnenAzacitidine Mylan · 4.8 · Elderly population There is limited safety information available with azacitidine in patients ≥ 85 years (with
Eintrag öffnenBesponsa · 4.8 · 11 available data). Within each frequency grouping, adverse reactions are presented in order of decreasing ser
Eintrag öffnenBetmiga · 4.8 · 32 MedDRA Common Uncommon Rare Very rare Not known System organ (cannot be class estimated from the available
Eintrag öffnenBetmiga · 4.8 · 8 MedDRA Common Uncommon Rare Very rare Not known System organ (cannot be class estimated from the available d
Eintrag öffnenBraftovi · 4.8 · 13 rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000), not known (cannot be estimated from the available d
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenCabometyx · 4.8 · 11 <1/10); uncommon (≥1/1,000 to <1/100); not known (cannot be estimated from the available data). Within each
Eintrag öffnen